Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06875323 · ClinicalTrials.gov registry record · NA
FostrSpace-CASA R61/R33
A NA study of Substance Use, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 1
- Study location
NCT06875323: Active NA study of Substance Use, sponsored by University of California, San Francisco.
NCT06875323 is a NA study of Substance Use that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 400 participants, below the 1,256-participant average among 88 other Substance Use trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06875323, a NA study of Substance Use, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to understand how an online digital health application (app) called FostrSpace can reduce substance use among youth (ages 13-20 years old) in foster care.
Conditions Studied
Interventions
- OTHER ECHO-FostrSpace
- OTHER Informational Session
Study Locations (1)
California
- UCSF Zuckerberg San Francisco General Hospital - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2024-03-01 |
| Est. Completion | 2029-03-01 |
| Phase | NA |
What the registry record for NCT06875323 still lists
NCT06875323 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,256-participant average among 88 other Substance Use trials with a reported enrollment target (68% lower).
The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which ECHO-FostrSpace is the first listed.
NCT06875323 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06875323 about?
NCT06875323 is a clinical study titled "FostrSpace-CASA R61/R33". The purpose of this study is to understand how an online digital health application (app) called FostrSpace can reduce substance use among youth (ages 13-20 years old) in foster care.
What is the current status of trial NCT06875323?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2024-03-01. Estimated completion is 2029-03-01.
What conditions does trial NCT06875323 study?
This clinical trial studies the following conditions: Substance Use.
What interventions are being tested in trial NCT06875323?
The interventions under investigation include: ECHO-FostrSpace (OTHER), Informational Session (OTHER).
Who is sponsoring clinical trial NCT06875323?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06875323 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06875323's enrollment target sits among peer trials
400 26th of 88 higher than 63 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI